glpg2737
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 25, 2016 (NCT03410979)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04578548 | Phase 2 | Nov 10, 2020 | Galapagos NV |
| NCT03540524 | Phase 1 | May 31, 2018 | Galapagos NV |
| NCT03474042 | Phase 2 | Nov 29, 2017 | Galapagos NV |
| NCT03450720 | Phase 1 | Jun 28, 2017 | Galapagos NV |
| NCT03410979 | Phase 1 | Nov 25, 2016 | Galapagos NV |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galapagos NV | For profit | 5 | 5 | 2 | 2016 |
1 organizations
Page 1 / 1